Abstract
Chemokine receptors CCR2 and CCR5 shape inflammatory responses by driving monocyte recruitment to sites of injury. Unfortunately, through the same mechanism they contribute to the formation of onco-protective tumor microenvironments in cancer and tissue fibrosis in chronic inflammatory conditions. These associations motivated targeting CCR2 and CCR5 in nonalcoholic fatty liver disease and pancreatic cancer, among others.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
